Financials data is unavailable for this security.
View more
Year on year Vitro Biopharma Inc had revenues fall -46.45% from 3.29m to 1.76m, though the company grew net income from a loss of 6.86m to a smaller loss of 5.36m.
Gross margin | 83.48% |
---|---|
Net profit margin | -495.08% |
Operating margin | -412.25% |
Return on assets | -136.91% |
---|---|
Return on equity | -- |
Return on investment | -1,046.98% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Vitro Biopharma Inc fell by 639.79k. Cash Flow from Financing totalled 1.52m or 86.45% of revenues. In addition the company used 1.97m for operations while cash used for investing totalled 195.43k.
Cash flow per share | -2.29 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -1.69 |
---|---|
Tangible book value per share | -2.66 |
More ▼
Balance sheet in USDView more
Current ratio | 0.204 |
---|---|
Quick ratio | 0.1865 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼